R.C.S.A. § 20-631-3
Content of patient protocol
Cite as Conn. Agencies Regs. § 20-631-3
A written protocol for a specific patient established pursuant to a collaborative drug therapy management agreement shall include, but need not be limited to, the following:
(1) The specific drug or drugs to be managed by the pharmacist;
(2) The terms and conditions under which drug therapy may be implemented, modified or discontinued;
(3) The conditions and events that the pharmacist is required to report to the physician;
(4) The laboratory tests that may be ordered by the pharmacist; and
(5) The drugs that may be administered by the pharmacist.